# Nauticus Robotics, Inc.: financial statements, quarterly

KITT · Nasdaq · CIK 1849820 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kitt.md) · [Financials](/companies/kitt/financials.md) · [Filings](/companies/kitt/filings.md) · [Insiders](/companies/kitt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kitt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.6](/filings/0001849820-25-000106.md) | [1.1 d](/filings/0001849820-25-000108.md) | [0.5](/filings/0001849820-25-000128.md) | [0.5](/filings/0001849820-25-000211.md) | [0.4](/filings/0001849820-25-000278.md) | [0.5 d](/filings/0001849820-26-000051.md) | [0.2](/filings/0001849820-26-000090.md) | [2.1](/filings/0001849820-26-000125.md) | [2.0](/filings/0001849820-25-000278.md) | [1.1 d](/filings/0001849820-26-000051.md) | [0.2](/filings/0001849820-26-000090.md) | [0.9](/filings/0001849820-26-000125.md) |
| Cost of revenue | $m | [2.7](/filings/0001213900-23-087010.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [0.3](/filings/0001849820-25-000106.md) | [0.4 d](/filings/0001849820-25-000108.md) | [0.1](/filings/0001849820-25-000128.md) | [0.0](/filings/0001849820-25-000211.md) | [0.0](/filings/0001849820-25-000278.md) | [0.0 d](/filings/0001849820-26-000051.md) | [0.0](/filings/0001849820-25-000128.md) | [0.0](/filings/0001849820-25-000211.md) | [0.0](/filings/0001849820-25-000278.md) | [0.0 d](/filings/0001849820-26-000051.md) | not reported | not reported |
| Operating income | $m | [(8.2)](/filings/0001849820-25-000106.md) | [(34.2) d](/filings/0001849820-25-000108.md) | [(5.5)](/filings/0001849820-25-000128.md) | [(6.0)](/filings/0001849820-25-000211.md) | [(5.6)](/filings/0001849820-25-000278.md) | [(6.2) d](/filings/0001849820-26-000051.md) | [(5.9)](/filings/0001849820-26-000090.md) | [(6.4)](/filings/0001849820-26-000125.md) | [(5.9)](/filings/0001849820-25-000278.md) | [(5.6) d](/filings/0001849820-26-000051.md) | [(5.7)](/filings/0001849820-26-000090.md) | [(6.0)](/filings/0001849820-26-000125.md) |
| Interest expense | $m | [4.3](/filings/0001849820-25-000106.md) | [4.5 d](/filings/0001849820-25-000108.md) | [1.5](/filings/0001849820-25-000128.md) | [1.2](/filings/0001849820-25-000211.md) | [1.2](/filings/0001849820-25-000278.md) | [1.3 d](/filings/0001849820-26-000051.md) | [1.1](/filings/0001849820-26-000090.md) | [1.2](/filings/0001849820-26-000125.md) | [1.2](/filings/0001849820-25-000278.md) | [5.2 d](/filings/0001849820-26-000051.md) | [1.0](/filings/0001849820-26-000090.md) | [0.8](/filings/0001849820-26-000125.md) |
| Income tax | $m | [0.0 d](/filings/0001849820-25-000106.md) | [0.0 d](/filings/0001849820-25-000108.md) | [0.0](/filings/0001849820-25-000128.md) | [0.0](/filings/0001849820-25-000211.md) | [0.0](/filings/0001849820-25-000278.md) | [0.0 d](/filings/0001849820-26-000051.md) | [0.0](/filings/0001849820-26-000090.md) | [0.0](/filings/0001849820-26-000125.md) | [0.0](/filings/0001849820-25-000278.md) | [0.0 d](/filings/0001849820-26-000051.md) | [0.0](/filings/0001849820-26-000090.md) | [0.0](/filings/0001849820-26-000125.md) |
| Net income | $m | [(17.7)](/filings/0001849820-25-000106.md) | [(39.5) d](/filings/0001849820-25-000108.md) | [(72.8)](/filings/0001849820-25-000128.md) | [4.5](/filings/0001849820-25-000211.md) | [17.9](/filings/0001849820-25-000278.md) | [(84.5) d](/filings/0001849820-26-000051.md) | [(7.6)](/filings/0001849820-26-000090.md) | [(7.5)](/filings/0001849820-26-000125.md) | [(6.6)](/filings/0001849820-25-000278.md) | [(19.2) d](/filings/0001849820-26-000051.md) | [(9.3)](/filings/0001849820-26-000090.md) | [(11.1)](/filings/0001849820-26-000125.md) |
| Diluted EPS | $ per share | [(15.46)](/filings/0001849820-25-000106.md) | not reported | [(58.75)](/filings/0001849820-25-000128.md) | [(1.12)](/filings/0001849820-25-000211.md) | [(3.23)](/filings/0001849820-25-000278.md) | not reported | [(19.85)](/filings/0001849820-26-000090.md) | [(18.50)](/filings/0001849820-26-000125.md) | [(2.60)](/filings/0001849820-25-000278.md) | not reported | [(2.46)](/filings/0001849820-26-000090.md) | [(2.11)](/filings/0001849820-26-000125.md) |
| Basic EPS | $ per share | [(15.46)](/filings/0001849820-25-000106.md) | not reported | [(58.75)](/filings/0001849820-25-000128.md) | [2.33](/filings/0001849820-25-000211.md) | [60.31](/filings/0001849820-25-000278.md) | not reported | [(19.85)](/filings/0001849820-26-000090.md) | [(18.50)](/filings/0001849820-26-000125.md) | [(2.60)](/filings/0001849820-25-000278.md) | not reported | [(2.46)](/filings/0001849820-26-000090.md) | [(2.11)](/filings/0001849820-26-000125.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.8](/filings/0001213900-23-087010.md) | [0.8](/filings/0001849820-25-000108.md) | [6.2](/filings/0001849820-25-000097.md) | [8.1](/filings/0001849820-25-000099.md) | [2.9](/filings/0001849820-25-000106.md) | [1.2](/filings/0001849820-26-000051.md) | [10.1](/filings/0001849820-26-000090.md) | [2.7](/filings/0001849820-26-000125.md) | [5.5](/filings/0001849820-25-000278.md) | [7.0](/filings/0001849820-26-000125.md) | [5.3](/filings/0001849820-26-000090.md) | [1.4](/filings/0001849820-26-000125.md) |
| Current assets | $m | [27.9](/filings/0001213900-23-087010.md) | [9.2](/filings/0001849820-25-000108.md) | [11.8](/filings/0001849820-25-000097.md) | [13.1](/filings/0001849820-25-000099.md) | [7.3](/filings/0001849820-25-000106.md) | [4.3](/filings/0001849820-26-000051.md) | [13.9](/filings/0001849820-25-000128.md) | [8.0](/filings/0001849820-25-000211.md) | [9.6](/filings/0001849820-25-000278.md) | [9.3](/filings/0001849820-26-000125.md) | [7.6](/filings/0001849820-26-000090.md) | [4.1](/filings/0001849820-26-000125.md) |
| Total assets | $m | [56.3](/filings/0001213900-23-087010.md) | [26.1](/filings/0001849820-25-000108.md) | [29.4](/filings/0001849820-25-000097.md) | [31.2](/filings/0001849820-25-000099.md) | [25.0](/filings/0001849820-25-000106.md) | [22.7](/filings/0001849820-26-000051.md) | [48.5](/filings/0001849820-25-000128.md) | [41.9](/filings/0001849820-25-000211.md) | [42.8](/filings/0001849820-25-000278.md) | [42.6](/filings/0001849820-26-000125.md) | [40.2](/filings/0001849820-26-000090.md) | [35.9](/filings/0001849820-26-000125.md) |
| Current liabilities | $m | [13.0](/filings/0001213900-23-087010.md) | [17.4](/filings/0001849820-25-000108.md) | [13.7](/filings/0001849820-25-000097.md) | [10.9](/filings/0001849820-25-000099.md) | [9.9](/filings/0001849820-25-000106.md) | [12.3](/filings/0001849820-26-000051.md) | [17.8](/filings/0001849820-25-000128.md) | [18.3](/filings/0001849820-25-000211.md) | [46.5](/filings/0001849820-25-000278.md) | [35.4](/filings/0001849820-26-000125.md) | [35.4](/filings/0001849820-26-000090.md) | [30.5](/filings/0001849820-26-000125.md) |
| Total liabilities | $m | [59.0](/filings/0001213900-23-087010.md) | [67.9](/filings/0001849820-25-000108.md) | [142](/filings/0001849820-25-000097.md) | [123](/filings/0001849820-25-000099.md) | [91.5](/filings/0001849820-25-000106.md) | [43.1](/filings/0001849820-26-000051.md) | [47.0](/filings/0001849820-25-000128.md) | [47.6](/filings/0001849820-25-000211.md) | [46.9](/filings/0001849820-25-000278.md) | [35.6](/filings/0001849820-26-000125.md) | [36.0](/filings/0001849820-26-000090.md) | [30.7](/filings/0001849820-26-000125.md) |
| Long-term debt | $m | [29.9](/filings/0001213900-23-087010.md) | [31.6](/filings/0001849820-24-000029.md) | [119](/filings/0001849820-25-000097.md) | [109](/filings/0001849820-25-000099.md) | [79.4](/filings/0001849820-25-000106.md) | [28.9](/filings/0001849820-25-000278.md) | [27.5](/filings/0001849820-25-000128.md) | [27.7](/filings/0001849820-25-000211.md) | [30.0](/filings/0001849820-25-000278.md) | [21.8](/filings/0001849820-26-000125.md) | [23.9](/filings/0001849820-26-000090.md) | [21.6](/filings/0001849820-26-000125.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001849820-25-000211.md) | [2.4](/filings/0001849820-25-000128.md) | [2.4](/filings/0001849820-25-000211.md) | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.6](/filings/0001849820-26-000090.md) | [0.3](/filings/0001849820-26-000125.md) |
| Shareholders' equity | $m | [(2.7)](/filings/0001849820-25-000106.md) | [(41.8)](/filings/0001849820-26-000051.md) | [(113)](/filings/0001849820-25-000211.md) | [(91.5)](/filings/0001849820-25-000278.md) | [(66.5)](/filings/0001849820-25-000278.md) | [(20.4)](/filings/0001849820-26-000125.md) | [1.5](/filings/0001849820-26-000125.md) | [(5.7)](/filings/0001849820-26-000125.md) | [(4.1)](/filings/0001849820-25-000278.md) | [7.0](/filings/0001849820-26-000125.md) | [4.2](/filings/0001849820-26-000125.md) | [5.2](/filings/0001849820-26-000125.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,614) d](/filings/0001849820-25-000106.md) | [(5,061) d](/filings/0001849820-25-000108.md) | [(6,660)](/filings/0001849820-25-000128.md) | [(8,391) d](/filings/0001849820-25-000211.md) | [(5,077) d](/filings/0001849820-25-000278.md) | [(4,223) d](/filings/0001849820-26-000051.md) | [(6,649)](/filings/0001849820-26-000090.md) | [(7,356) d](/filings/0001849820-26-000125.md) | [(4,938) d](/filings/0001849820-25-000278.md) | [(4,061) d](/filings/0001849820-26-000051.md) | [(7,006)](/filings/0001849820-26-000090.md) | [(7,120) d](/filings/0001849820-26-000125.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.5](/filings/0001213900-23-087010.md) | [39.8](/filings/0001849820-25-000097.md) | [1.2](/filings/0001849820-25-000099.md) | [1.1](/filings/0001849820-25-000106.md) | [1.2](/filings/0001849820-25-000128.md) | [5.4](/filings/0001849820-25-000211.md) | [1.7](/filings/0001849820-25-000278.md) | [0.4](/filings/0001849820-26-000090.md) | [0.4](/filings/0001849820-26-000125.md) | [3.9](/filings/0001849820-25-000278.md) | [3.8](/filings/0001849820-26-000090.md) | [5.4](/filings/0001849820-26-000125.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,471,960 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001849820-26-000125.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.